T. Rowe Price Associates’s Genprex GNPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-315
| Closed | -$12K | – | 2903 |
|
|
2023
Q1 | $12K | Sell |
315
-325
| -51% | -$12.4K | ﹤0.01% | 2874 |
|
|
2022
Q4 | $37K | Sell |
640
-1,048
| -62% | -$60.6K | ﹤0.01% | 2842 |
|
|
2022
Q3 | $96K | Sell |
1,688
-322
| -16% | -$18.3K | ﹤0.01% | 2734 |
|
|
2022
Q2 | $112K | Buy |
2,010
+82
| +4% | +$4.57K | ﹤0.01% | 2729 |
|
|
2022
Q1 | $174K | Hold |
1,928
| – | – | ﹤0.01% | 2736 |
|
|
2021
Q4 | $101K | Buy |
1,928
+758
| +65% | +$39.7K | ﹤0.01% | 2868 |
|
|
2021
Q3 | $125K | Buy |
1,170
+227
| +24% | +$24.3K | ﹤0.01% | 2796 |
|
|
2021
Q2 | $126K | Buy |
943
+14
| +2% | +$1.87K | ﹤0.01% | 2805 |
|
|
2021
Q1 | $160K | Sell |
929
-90
| -9% | -$15.5K | ﹤0.01% | 2729 |
|
|
2020
Q4 | $169K | Sell |
1,019
-215
| -17% | -$35.7K | ﹤0.01% | 2576 |
|
|
2020
Q3 | $166K | Buy |
1,234
+410
| +50% | +$55.2K | ﹤0.01% | 2454 |
|
|
2020
Q2 | $103K | Buy |
824
+449
| +120% | +$56.1K | ﹤0.01% | 2425 |
|
|
2020
Q1 | $36K | Buy |
+375
| New | +$36K | ﹤0.01% | 2470 |
|